The efficacy of GLP-1 receptor agonist on glycemic control in type 2 diabetes with inadequate DPP-4 inhibitor therapy.
Phase of Trial: Phase III
Latest Information Update: 12 May 2016
At a glance
- Drugs Liraglutide (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ND
- 30 Jul 2014 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 08 Apr 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 03 Feb 2012 New trial record